Table 1.
Demographic and clinical characteristics of full patient population*
| All stages | All NSCLC | NSQ | SQ | NSCLC NOS | Other NSCLC | Clinically diagnosed unknown pathology |
| N=3739 | n=1112 | n=819 | n=439 | n=88 | n=1281 | |
| Age, years | ||||||
| Mean (SD) | 72.3 (10.9) | 68.6 (11.0) | 70.8 (9.4) | 68.9 (10.6) | 70.1 (10.7) | 78.0 (9.3) |
| Median (Q1–Q3) | 73 (65–80) | 69 (62–77) | 71 (64–77) | 69 (63–77) | 71 (63–78) | 79 (72–85) |
| Range | 18–101 | 31–101 | 33–96 | 18–92 | 42–91 | 43–99 |
| Male, n (%) | 1881 (50.3) | 519 (46.7) | 505 (61.7) | 220 (50.1) | 49 (55.7) | 588 (45.9) |
| TNM stage, n (%) | ||||||
| I | 717 (19.2) | 223 (20.1) | 127 (15.5) | 30 (6.8) | 19 (21.6) | 318 (24.8) |
| II | 434 (11.6) | 113 (10.2) | 132 (16.1) | <40 (<9.1) | <13 (<14.8) | 137 (10.7) |
| IIIA | 469 (12.5) | 110 (9.9) | 164 (20.0) | 54 (12.3) | 8 (9.1) | 133 (10.4) |
| IIIB | 337 (9.0) | 89 (8.0) | 117 (14.3) | <55 (<12.3) | <5 (<6.0) | 77 (6.0) |
| IV | 1782 (47.7) | 577 (51.9) | 279 (34.1) | 263 (59.9) | 47 (53.4) | 616 (48.1) |
| Pathology, n (%) | ||||||
| Adenocarcinoma | 1019 (27.3) | 1019 (91.6) | 0 | 0 | 0 | 0 |
| SQ | 819 (21.9) | 0 | 819 (100.0) | 0 | 0 | 0 |
| NSCLC NOS | 439 (11.7) | 0 | 0 | 439 (100.0) | 0 | 0 |
| Large cell carcinoma | 93 (2.5) | 93 (8.4) | 0 | 0 | 0 | 0 |
| Other NSCLC | 88 (2.4) | 0 | 0 | 0 | 88 (100.0) | 0 |
| Clinically diagnosed, unknown pathology | 1281 (34.3) | 0 | 0 | 0 | 0 | 1281 (100.0) |
| WHO performance score, n (%) | ||||||
| 0 | 292 (7.8) | 149 (13.4) | 70 (8.6) | 38 (8.7) | 12 (13.6) | 23 (1.8) |
| 1 | 1031 (27.6) | 445 (40.0) | 319 (39.0) | 144 (32.8) | 37 (42.2) | 86 (6.7) |
| 2 | 758 (20.3) | 230 (20.7) | 230 (28.1) | 80 (18.2) | 25 (28.4) | 193 (15.1) |
| 3 | 933 (25.0) | 154 (13.9) | 118 (14.4) | 97 (22.1) | <15 (<17.0) | 553 (43.2) |
| 4 | 372 (10.0) | 39 (3.5) | 16 (2.0) | 26 (5.9) | 0 | 291 (22.7) |
| Missing | 353 (9.4) | 95 (8.5) | 66 (8.1) | <55 (<12.5) | <5 (<5.7) | 135 (10.5) |
*For some categories including low numbers of patients, data have been masked to conceal patient identities. Includes six patients diagnosed in 2006.
NOS, not otherwise specified; NSCLC, non-small cell lung cancer; NSQ, non-squamous cell carcinoma; Q, quartile; SQ, squamous cell carcinoma;; TNM, tumour, node and metastasis.